Two studies have shown that NF1-/- Schwann cell lineage cells differentiated from patient IPSCs can develop into neurofibromas in immunocompromised mice (Mazuelas et al. 2022; Mo et al. 2021). The gene discussed is NF1; the disease is neurofibroma.